<DOC>
	<DOCNO>NCT00273949</DOCNO>
	<brief_summary>The purpose study assess ability lactulose , prebiotic agent , prevent hospital acquire infection child</brief_summary>
	<brief_title>Lactulose Prevention Nosocomial Infections Children</brief_title>
	<detailed_description>Despite adoption norm regard enteric isolation , nosocomial infectious diarrhea common child ( 1 ; 2 ) . Viral pathogen , especially rotavirus responsible case . Depending population , type hospital , standard care , report incidence rate range 8 33 episode per 100 admission ( 1 ) . Infants toddler high risk acquire nosocomial viral gastroenteritis ( 1 ; 2 ) . Probiotic bacteria show beneficial prevention treatment gastrointestinal infection well reduction viral shedding ( 3 ; 4 ) . A recent study Szajewska et al . ( 2 ) show significant reduction nosocomial infection 33 % 7 % prophylactic treatment LGG hospital stay . Another study however , show difference ( 1 ) . Another approach use prebiotic treatment . Prebiotics define non-digestible substance , ingest , selectively promote growth establishment beneficial probiotic-like bacteria normally present gut ( 5 ) . Lactulose semi-synthetic disaccharide make lactose chemical reaction first described 1930 ( 6 ) . In contrast prebiotics , lactulose mainly use medicinal drug constipation hepatic encephalopathy ( 6 ) . In 1957 Petuely publish basic work lactulose `` bifidus factor '' confirm MacGillivray et al ( 6 ) .They find composition colonic microflora bottle-fed baby much like adult lactulose add formula milk baby composition breast-fed baby . Lactulose use 40 year treatment constipation [ 10 ] 30 year encephalopathy.The dosage use PSE four time higher usually apply constipation . No putative definite evidence mutagenic , genotoxic teratogenic effect lactulose obtain human use . Animal study rat rabbit also reveal teratogenic reproduction-toxicologic effect , even high dosage deleterious effect ( 6 ) Our hypothesis lactulose , proven prebiotic property , give child hospital stay , would beneficial reduce nosocomial infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>All child age 2 36 month admit hospital reason diarrhea eligible study . Children history probiotic prebiotics use within 7 day admission , acute gastroenteritis within 3 day admission , vomit , treat chronic constipation , know anatomic problem gastrointestinal tract exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Lactulose</keyword>
	<keyword>Prebiotics</keyword>
	<keyword>Nosocomial infection</keyword>
	<keyword>child</keyword>
	<keyword>infant</keyword>
</DOC>